LIGAND PHARMACEUTICALS INC's ticker is LGND and the CUSIP is 53220K504. A total of 363 filers reported holding LIGAND PHARMACEUTICALS INC in Q4 2018. The put-call ratio across all filers is 1.44 and the average weighting 0.3%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $9,690,476 | -11.6% | 145,067 | +14.0% | 0.00% | -33.3% |
Q3 2022 | $10,958,961 | +0.9% | 127,267 | +4.5% | 0.00% | 0.0% |
Q2 2022 | $10,864,587 | -23.4% | 121,773 | -3.4% | 0.00% | 0.0% |
Q1 2022 | $14,182,852 | -25.0% | 126,081 | +3.0% | 0.00% | -25.0% |
Q4 2021 | $18,915,000 | +41.7% | 122,456 | +27.8% | 0.00% | +33.3% |
Q3 2021 | $13,345,000 | +86.6% | 95,790 | +75.7% | 0.00% | +50.0% |
Q2 2021 | $7,152,000 | -59.2% | 54,513 | -52.6% | 0.00% | -50.0% |
Q1 2021 | $17,546,000 | +31.0% | 115,091 | -14.6% | 0.00% | +33.3% |
Q4 2020 | $13,396,000 | +3.7% | 134,704 | -0.6% | 0.00% | 0.0% |
Q3 2020 | $12,922,000 | -36.8% | 135,563 | -25.8% | 0.00% | -50.0% |
Q2 2020 | $20,444,000 | +32.3% | 182,782 | -14.0% | 0.01% | 0.0% |
Q1 2020 | $15,452,000 | -34.7% | 212,481 | -6.3% | 0.01% | -14.3% |
Q4 2019 | $23,646,000 | +0.8% | 226,729 | -3.8% | 0.01% | 0.0% |
Q3 2019 | $23,465,000 | -12.8% | 235,737 | 0.0% | 0.01% | -12.5% |
Q2 2019 | $26,910,000 | -9.2% | 235,737 | 0.0% | 0.01% | -20.0% |
Q1 2019 | $29,635,000 | -7.4% | 235,737 | 0.0% | 0.01% | -16.7% |
Q4 2018 | $31,990,000 | -47.7% | 235,737 | +5.8% | 0.01% | -40.0% |
Q3 2018 | $61,135,000 | +41.6% | 222,721 | +6.8% | 0.02% | +33.3% |
Q2 2018 | $43,184,000 | +33.4% | 208,449 | +6.3% | 0.02% | +25.0% |
Q1 2018 | $32,374,000 | +34.2% | 196,017 | +11.3% | 0.01% | +33.3% |
Q4 2017 | $24,116,000 | +12.4% | 176,117 | +11.8% | 0.01% | +12.5% |
Q3 2017 | $21,452,000 | +12.1% | 157,565 | 0.0% | 0.01% | 0.0% |
Q2 2017 | $19,128,000 | +17.3% | 157,565 | +2.3% | 0.01% | +14.3% |
Q1 2017 | $16,301,000 | -16.4% | 154,014 | -19.7% | 0.01% | -22.2% |
Q4 2016 | $19,500,000 | +4.2% | 191,907 | 0.0% | 0.01% | 0.0% |
Q3 2016 | $18,707,000 | -12.2% | 191,907 | +7.5% | 0.01% | -10.0% |
Q2 2016 | $21,297,000 | +29.0% | 178,565 | +15.8% | 0.01% | +25.0% |
Q1 2016 | $16,510,000 | -1.2% | 154,165 | 0.0% | 0.01% | 0.0% |
Q4 2015 | $16,715,000 | +26.6% | 154,165 | 0.0% | 0.01% | +14.3% |
Q3 2015 | $13,204,000 | +109.7% | 154,165 | +147.0% | 0.01% | +133.3% |
Q2 2015 | $6,298,000 | +111.9% | 62,417 | +61.9% | 0.00% | +200.0% |
Q1 2015 | $2,972,000 | +44.9% | 38,543 | 0.0% | 0.00% | 0.0% |
Q4 2014 | $2,051,000 | – | 38,543 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Knott David M Jr | 115,000 | $12,937,000 | 4.12% |
Stonepine Capital Management, LLC | 73,700 | $8,291,000 | 3.44% |
VILLERE ST DENIS J & CO LLC | 510,843 | $57,464,000 | 3.41% |
Chicago Capital, LLC | 491,717 | $55,313,000 | 2.38% |
Orchard Capital Management, LLC | 73,596 | $8,279,000 | 2.35% |
RICE HALL JAMES & ASSOCIATES, LLC | 344,969 | $38,806,000 | 1.55% |
Smith, Graham & Co., Investment Advisors, LP | 86,834 | $9,768,000 | 1.02% |
WOODSTOCK CORP | 64,050 | $7,205,000 | 0.84% |
INVESTMENT MANAGEMENT OF VIRGINIA LLC | 37,246 | $4,190,000 | 0.74% |
Stephens Investment Management Group LLC | 417,670 | $46,984,000 | 0.69% |